共 83 条
- [11] Osby U., Westman J., Hallgren J., Gissler M., Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987-2010, Eur J Pub Health, 26, pp. 867-871, (2016)
- [12] Sui X., Liu T., Liang Y., Zhang B., Psychiatric disorders and cardiovascular diseases: a mendelian randomization study, Heliyon, 9, (2023)
- [13] Page M.J., McKenzie J.E., Bossuyt P.M., Et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372, (2021)
- [14] Wells G., Shea B., O'Connell D., The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, (2009)
- [15] DerSimonian R., Laird N., Meta-analysis in clinical trials, Control Clin Trials, 7, pp. 177-188, (1986)
- [16] Ades A.E., Lu G., Higgins J.P., The interpretation of random-effects meta-analysis in decision models, Med Decis Mak, 25, pp. 646-654, (2005)
- [17] Deeks J.J., Higgins J.P.T., Altman D.G., Analyzing data and undertaking meta-analyses, Cochrane handbook for systematic reviews of interventions 5.0.1, (2008)
- [18] Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G., Measuring inconsistency in meta-analyses, BMJ, 327, pp. 557-560, (2003)
- [19] Tobias A., Assessing the influence of a single study in meta-analysis, Stata Tech Bull, 47, pp. 15-17, (1999)
- [20] Altman D.G., Bland J.M., Interaction revisited: the difference between two estimates, BMJ, 326, (2003)